| Memon, Muhammad |
| Completed | 4 | 24 | US | Fecal Microbiota Transplant, FMT | Methodist Health System | Clostridium Difficile Infection | 03/22 | 03/22 | | |
| Tarnasky, Paul |
| Active, not recruiting | N/A | 500 | US | Acute Pancreatitis | Methodist Health System | Acute Pancreatitis | 04/25 | 06/25 | | |
| Lin, Feng |
NCT05182463: Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients |
|
|
| Recruiting | 4 | 5000 | RoW | Peginterferon Alfa-2B, Nucleoside Analogs | Third Affiliated Hospital, Sun Yat-Sen University | Hepatitis B, Chronic | 12/26 | 11/29 | | |
NCT05395416: Antaitavir Hasophate Capsules Combined With Yiqibuvir Tablets in Treatment Adult Patients With Chronic Hepatitis C |
|
|
| Recruiting | 2/3 | 520 | RoW | HEC74647PA+HEC110114, Antaitavir Hasophate+Yiqibuvir, Placebo | Sunshine Lake Pharma Co., Ltd. | Chronic HCV Infection | 04/23 | 04/23 | | |
NCT04147208: Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection |
|
|
| Completed | 2 | 250 | RoW | GLS4, Morphothiadine Mesilate Capsules, RTV, Ritonavir tablet, ETV, Entecavir table | Sunshine Lake Pharma Co., Ltd. | Chronic HBV Infection | 06/22 | 09/23 | | |
| Recruiting | 2 | 114 | US | RFB, VSOP, IR | University of Rochester, Stanford University | Mild Cognitive Impairment, Healthy Aging | 02/26 | 02/26 | | |
NCT05970666: Single Arm, Prospective, Multicenter Clinical Study of TACE With Adebrelimab and Bevacizumab for Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | 2 | 71 | RoW | TACE with adebrelimab and bevacizumab | The First Affiliated Hospital of Xiamen University, Jiangsu HengRui Medicine Co., Ltd. | Adebrelimab, Hepatocellular Carcinoma, Transformation, Bevacizumab, TACE | 11/26 | 11/26 | | |
NCT03108794: A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B |
|
|
| Recruiting | N/A | 200000 | RoW | | Beijing Friendship Hospital, Beijing YouAn Hospital, The First Hospital of Jilin University, Henan Provincial People's Hospital, Beijing Ditan Hospital, First Affiliated Hospital of Xinjiang Medical University, LanZhou University, The Second Affiliated Hospital of Chongqing Medical University, West China Hospital, Taiyuan No.3 Hospital, Hebei Medical University Third Hospital, Shengjing Hospital, Tianjin Third Central Hospital, Peking University First Hospital, Peking Union Medical College Hospital, The Affiliated Hospital Of Southwest Medical University, Shanghai Public Health Clinical Center, Ruijin Hospital, First Affiliated Hospital Xi'an Jiaotong University, Xiangya Hospital of Central South University, Beijing Tiantan Hospital, Wuhan University, The First Affiliated Hospital of Kunming Medical College, The Affiliated Hospital of Xuzhou Medical University, The Affiliated Hospital of Yanbian University, First Affiliated Hospital of Chongqing Medical University, The Fouth Hospital of Qinghai province, Weifang Medical University, Hunan Provincial People's Hospital, The Second Hospital of Hebei Medical University, Xixi Hospital of Hangzhou, General Hospital of Ningxia Medical University, Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology, Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital, Peking University People's Hospital, Nanfang Hospital of Southern Medical University, The Affiliated Hospital Of Guizhou Medical University, Guizhou Provincial People's Hospital, Hainan General Hospital, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Fifth Hospital of Shijiazhuang City, Yan'an University Affiliated Hospital, Infectious Disease Hospital of Wuhai, Logistics University of Chinese People's Armed Police Forces, People's Hospital of Changji Hui Autonomous Prefecture，Xinjiang | Chronic Hepatitis B | 12/22 | 12/25 | | |
NCT06096077: Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department |
|
|
| Completed | N/A | 50 | US | | Methodist Health System | Angioedema | 08/23 | 08/23 | | |
NCT05106725: Wearable Devices and Biomarkers Project (Healthiomics) |
|
|
| Recruiting | N/A | 3500 | US | | CureScience | Brain Cancer, Neurological Disorder, Neurological Cancer | 12/25 | 12/25 | | |
NCT05409482: A Real-world Study of Camrelizumab Combined With Apatinib Mesylate in Unresectable Hepatocellular Carcinoma |
|
|
| Recruiting | N/A | 300 | RoW | | Meng Chao Hepatobiliary Hospital of Fujian Medical University, Suzhou Suncadia Biopharmaceuticals Co., Ltd. | Hepatocellular Carcinoma | 03/26 | 03/26 | | |
NCT05937178: Real-world Study Optimizing Nucleotide-analogues |
|
|
| Recruiting | N/A | 20000 | RoW | ETV/TAF/TDF/TMF/IFN, ETV/TAF/TDF/TMF | Huashan Hospital, The First Affiliated Hospital of Anhui Medical University, Anhui Provincial Hospital, Beijing YouAn Hospital, Peking University People's Hospital, Peking University First Hospital, Xiamen Hospital of Traditional Chinese Medicine, First Affiliated Hospital of Fujian Medical University, LanZhou University, Third Affiliated Hospital, Sun Yat-Sen University, First Affiliated Hospital of Guangxi Medical University, The Affiliated Hospital Of Guizhou Medical University, Hainan General Hospital, Hebei Medical University Third Hospital, The First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Henan Provincial People's Hospital, The Second Affiliated Hospital of Harbin Medical University, Tongji Hospital, Wuhan Union Hospital, China, Renmin Hospital of Wuhan University, Central South University, Xiangya Hospital of Central South University, The First Hospital of Jilin University, the Second Hospital of Nangjing, The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School, The First Affiliated Hospital with Nanjing Medical University, The Affiliated Hospital of Xuzhou Medical University, The First Affiliated Hospital of Nanchang University, Shengjing Hospital, Qingdao Sixth People's Hospital, Shandong Provincial Hospital Affiliated to Shandong First Medical University, The Second Hospital of Shandong University, The First Affiliated Hospital of Shanxi Medical University, Tang-Du Hospital, First Affiliated Hospital Xi'an Jiaotong University, Ruijin Hospital, West China Hospital, Tianjin Second People's Hospital, First Affiliated Hospital of Xinjiang Medical University, The First People's Hospital of Yunnan, Shulan (Hangzhou) Hospital, Zhejiang University, Southwest Hospital, China, The Second Affiliated Hospital of Chongqing Medical University, Sichuan Provincial People's Hospital | Hepatitis B, Chronic | 01/29 | 01/29 | | |
| Bageac, Alexandru |
NCT04903548: Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres |
|
|
| Recruiting | N/A | 300 | US | SIRT with Y-90 resin microspheres | Methodist Health System | Hepatocellular Carcinoma | 12/24 | 12/24 | | |
NCT05995236: Prostate-Specific Membrane Antigen (PSMA) Radionuclide Therapy |
|
|
| Recruiting | N/A | 400 | US | PSMA radionuclide therapy | Methodist Health System | Prostate Cancer | 08/24 | 08/24 | | |
| Patel, Chirag |
NAVIGATE, NCT04365868: Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis |
|
|
| Active, not recruiting | 2b | 357 | Europe, Canada, US, RoW | belapectin, GR-MD-02, galactoarabino rhamnogalacturonate, Placebo | Galectin Therapeutics Inc. | Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis, Cirrhosis | 12/24 | 12/24 | | |
VISTAS, NCT04663308: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) |
|
|
| Recruiting | 2 | 200 | Europe, Canada, US, RoW | Volixibat, SHP626, Placebo | Mirum Pharmaceuticals, Inc. | Primary Sclerosing Cholangitis | 09/25 | 12/25 | | |
NCT05305365: Study Assessing QBS72S For Treating Brain Metastases |
|
|
| Recruiting | 2 | 40 | US | QBS72S, QBS10072S | Melanie Hayden Gephart, Quadriga Biosciences, Inc. | Brain Metastases, Breast Cancer | 02/25 | 08/26 | | |
| Burris, Jennifer |
NCT06336889: Pelvic Angioembolization: A Prospective Multi-Institutional Study (Data From All Campuses Will be Used) |
|
|
| Recruiting | N/A | 400 | US | Pelvic Angioembolization | Methodist Health System | Pelvic Hemorrhage | 10/24 | 10/24 | | |
NCT05224635: The PROspective Observational Vascular Injury Trial (PROOVIT) |
|
|
| Enrolling by invitation | N/A | 5718 | US | Vascular Injury | Methodist Health System | Vascular Injury | 12/24 | 12/24 | | |
NCT05085353: Fetal Outcomes Among Pregnant Emergency General Surgery Patients |
|
|
| Enrolling by invitation | N/A | 50 | US | non-obstetric acute general surgical disease | Methodist Health System | Pregnancy Complications, Acute Appendicitis, Acute Cholecystitis, Biliary Pancreatitis, Bowel Obstruction, Acute Diverticulitis | 02/25 | 02/25 | | |
| Mantry, Parvez |
NCT01846663: Efficacy, Safety, And Pharmacokinetics Of Rifaximin In Subjects With Severe Hepatic Impairment And Hepatic Encephalopathy |
|
|
| Terminated | 4 | 6 | US | Placebo, Rifaximin, XIFAXAN® Tablets | Bausch Health Americas, Inc. | Hepatic Encephalopathy | 02/16 | 02/16 | | |
NATiV3, NCT04849728: A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( ) |
|
|
| Recruiting | 3 | 1000 | Europe, Canada, US, RoW | IVA337, Lanifibranor, Placebo | Inventiva Pharma | NASH - Nonalcoholic Steatohepatitis | 09/25 | 09/26 | | |
NAVIGATE, NCT04365868: Study Evaluating the Efficacy and Safety of Belapectin for the Prevention of Esophageal Varices in NASH Cirrhosis |
|
|
| Active, not recruiting | 2b | 357 | Europe, Canada, US, RoW | belapectin, GR-MD-02, galactoarabino rhamnogalacturonate, Placebo | Galectin Therapeutics Inc. | Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis, Cirrhosis | 12/24 | 12/24 | | |
| Recruiting | 2 | 50 | Europe, US | INT-787, Placebo | Intercept Pharmaceuticals | Alcohol Associated Hepatitis | 12/24 | 12/24 | | |
NCT04919642: Study to Evaluate the Efficacy and Safety of TT-00420 (Tinengotinib) in Cholangiocarcinoma |
|
|
| Completed | 2 | 55 | US | TT-00420 | TransThera Sciences (Nanjing), Inc. | Cholangiocarcinoma, FGFR2 Fusion, FGFR2 Gene Mutation, FGFR1 Alteration, FGFR3 Alteration | 02/24 | 02/24 | | |
PACIFIC, NCT05525520: Study to Evaluate EP547 in Subjects With Cholestatic Pruritus Due to Primary Biliary Cholangitis or Primary Sclerosing Cholangitis |
|
|
| Active, not recruiting | 2 | 58 | Europe, Canada, US, RoW | EP547, Placebo | Escient Pharmaceuticals, Inc | Pruritus | 07/24 | 09/24 | | |
NCT05239468: Study of OCA in Combination With BZF Evaluating Efficacy, Safety and Tolerability in Participants With PBC |
|
|
| Active, not recruiting | 2 | 60 | US | Bezafibrate 100 mg, Bezafibrate 200 mg, Obeticholic Acid 5 mg, Obeticholic Acid placebo, Bezafibrate Placebo | Intercept Pharmaceuticals | Primary Biliary Cholangitis | 11/24 | 02/25 | | |
| Active, not recruiting | 2 | 68 | Europe, US, RoW | Anti-human CCL24 monoclonal antibody (CM-101), Placebo | ChemomAb Ltd. | Primary Sclerosing Cholangitis | 09/24 | 09/25 | | |
VISTAS, NCT04663308: A Study to Evaluate Efficacy and Safety of an Investigational Drug Named Volixibat in Patients With Itching Caused by Primary Sclerosing Cholangitis (PSC) |
|
|
| Recruiting | 2 | 200 | Europe, Canada, US, RoW | Volixibat, SHP626, Placebo | Mirum Pharmaceuticals, Inc. | Primary Sclerosing Cholangitis | 09/25 | 12/25 | | |
NCT04505436: Study to Evaluate Efficacy, Safety and Tolerability of HM15211 in Subjects |
|
|
| Recruiting | 2 | 240 | US, RoW | HM15211, Placebo of HM15211 | Hanmi Pharmaceutical Company Limited | NASH - Nonalcoholic Steatohepatitis | 05/25 | 11/25 | | |
FOENIX-CCA4, NCT05727176: Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement |
|
|
| Recruiting | 2 | 120 | Europe, Japan, US, RoW | TAS-120, Futibatinib | Taiho Oncology, Inc. | Advanced Cholangiocarcinoma, FGFR2 Fusions, Gene Rearrangement | 06/25 | 06/26 | | |
| Recruiting | 2 | 246 | Europe, Canada, Japan, US, RoW | GSK4532990, Placebo | GlaxoSmithKline | Nonalcoholic Fatty Liver Disease | 09/25 | 12/25 | | |
NCT06225206: Analysis of Donor-derived Cell Free DNA in Liver Transplant Patients |
|
|
| Recruiting | N/A | 300 | US | donor-derived cell free DNA in liver | Methodist Health System | Liver Transplant Failure | 12/24 | 12/24 | | |
NCT05170854: The Impact of Liver Cirrhosis on Outcomes in Trauma Patients |
|
|
| Completed | N/A | 4774035 | US | | Methodist Health System | Cirrhosis | 09/20 | 09/20 | | |
NCT06225193: Exploratory Analysis of Enhanced Liver Function (ELF) Test to Detect Early Fatty Liver in High Risk Population |
|
|
| Recruiting | N/A | 300 | US | | Methodist Health System | Fatty Liver | 06/24 | 06/24 | | |
NCT04903548: Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres |
|
|
| Recruiting | N/A | 300 | US | SIRT with Y-90 resin microspheres | Methodist Health System | Hepatocellular Carcinoma | 12/24 | 12/24 | | |
| Recruiting | N/A | 30 | US | | Methodist Health System | Alcoholic Hepatitis, Acute Liver Failure | 12/24 | 12/24 | | |
NCT05935800: The Effect of the COVID-19 Pandemic on Frailty in Liver Transplant Candidates |
|
|
| Active, not recruiting | N/A | 208 | US | COVID Patients who Underwent pre-transplant frailty assessment (PFA) at MDMC | Methodist Health System | Frailty, Sarcopenia, COVID-19 | 04/24 | 04/24 | | |
NCT06095440: A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center |
|
|
| Recruiting | N/A | 500 | US | Hepatorenal Syndrome outcome in Patients at Methodist Health systems, liver transplantation | Methodist Health System | Hepatorenal Syndrome | 05/24 | 05/24 | | |
DOORwaY90, NCT04736121: Selective Internal Radiation Therapy (SIRT) Using SIR-Spheres® Y-90 Resin Microspheres on DoR & ORR in Unresectable Hepatocellular Carcinoma Patients |
|
|
| Recruiting | N/A | 100 | US | Resin microspheres containing yttrium-90 (Y-90) | Sirtex Medical, Bright Research Partners | Unresectable Hepatocellular Carcinoma, BCLC Stage A Hepatocellular Carcinoma, BCLC Stage B Hepatocellular Carcinoma, BCLC Stage C Hepatocellular Carcinoma | 06/24 | 06/25 | | |
| Shahin, Islam |
NCT04903548: Evaluating the Effects of Selective Treatment Utilizing Flex-dosing for Unresectable HCC With Y90 SIR-Spheres |
|
|
| Recruiting | N/A | 300 | US | SIRT with Y-90 resin microspheres | Methodist Health System | Hepatocellular Carcinoma | 12/24 | 12/24 | | |
| Kedia, Prashant |
NCT06336850: Safety and Efficacy of Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement |
|
|
| Recruiting | N/A | 100 | US | Endoscopic Ultrasound-Guided Portal Pressure Gradient Measurement | Methodist Health System | Liver Diseases | 01/25 | 01/25 | | |
| Enrolling by invitation | N/A | 400 | US | Therapeutic Endoscopic ultrasound, T-EUS | Methodist Health System | Gastrointestinal Disease | 06/24 | 06/24 | | |
NCT04640753: Peroral Endoscopic Myotomy for the Treatment of Achalasia |
|
|
| Recruiting | N/A | 200 | US | Endoscopic procedure for achalasia | Methodist Health System | Achalasia | 02/24 | 02/24 | | |
NCT05170945: Early Routine Bowel Preparation for Suspected Acute Diverticular Bleeding |
|
|
| Recruiting | N/A | 415 | US | Early bowel preparation for colonoscopy | Methodist Health System | Diverticular Bleeding | 05/24 | 05/24 | | |
NCT04640688: Endoscopic Sleeve Gastroplasty / Endoscopic Sleeve Gastroplasty |
|
|
| Recruiting | N/A | 50 | US | Bariatric procedures | Methodist Health System | Obesity | 08/24 | 08/24 | | |
| Recruiting | N/A | 234 | Europe, Canada, US | ERCP with miES, EUS | Oregon Health and Science University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Pancreatitis, Pancreas Divisum, Pancreatitis, Acute, Pancreatitis Idiopathic, Pancreas Inflamed | 02/27 | 09/27 | | |
| Enrolling by invitation | N/A | 38 | US | ZPOEM, peroral endoscopic myotomy (POEM) | Methodist Health System, Baylor Scott and White Health | Zenker Diverticulum | 06/24 | 06/24 | | |
| Mejia, Alejandro |
| Enrolling by invitation | N/A | 100 | US | | Methodist Health System | Intrahepatic Cholangiocarcinoma, Liver Tumor, Metastatic Cancer, Metastatic Liver Cancer | 05/22 | 05/22 | | |
NCT04182607: Donor Outcomes Following Hand-Assisted And Robotic Living Donor Nephrectomy: A Retrospective Review |
|
|
| Recruiting | N/A | 240 | US | kidney transplant, nephrectomy | Methodist Health System | Transplant, Kidney Diseases | 11/22 | 11/22 | | |
| Recruiting | N/A | 30 | US | NanoKnife procedure | Methodist Health System | Pancreas Cancer | 12/24 | 12/24 | | |
NCT05087550: Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation |
|
|
| Completed | N/A | 186 | US | Liver Transplantation | Methodist Health System, Washington University School of Medicine | Liver Transplant | 06/23 | 08/23 | | |
NCT05224739: Validate the Difficulty Scoring System and Develop a Novel Scoring System for Laparoscopic and Robotic Liver Resections |
|
|
| Enrolling by invitation | N/A | 150 | US | Minimally Invasive Liver Resection | Methodist Health System | Liver Diseases | 11/24 | 11/24 | | |
| Recruiting | N/A | 300 | US | Observational Transplant Analysis, Predictive models of transplant usage | Methodist Health System | Identify More Accurate Predictive Models of Transplant Risk to Monitor and Evaluate New and Existing Patient Factors | 02/25 | 02/25 | | |
NCT06095440: A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center |
|
|
| Recruiting | N/A | 500 | US | Hepatorenal Syndrome outcome in Patients at Methodist Health systems, liver transplantation | Methodist Health System | Hepatorenal Syndrome | 05/24 | 05/24 | | |
NCT05128890: Evaluation of Resection Techniques for Pancreatic Tumors |
|
|
| Recruiting | N/A | 431 | US | Resection techniques for pancreatic and liver tumors, minimally invasive pancreatic resection techniques | Methodist Health System | Surgery, Liver Tumor, Pancreas Tumor | 04/25 | 04/25 | | |
NCT02674100: American Hepato-Pancreato-Biliary Association (AHPBA) Pancreatic Irreversible Electroporation (IRE) Registry |
|
|
| Recruiting | N/A | 500 | Europe, Canada, Japan, US, RoW | Registry | University of Louisville, The Americas Hepato-Pancreato-Biliary Association | Pancreatic Cancer | 01/25 | 01/30 | | |
PRRT, NCT04090034: Peptide Receptor Radionuclide Therapy () for the Treatment of Neuroendocrine Tumors |
|
|
| Recruiting | N/A | 50 | US | Peptide Receptor Radionuclide Therapy | Methodist Health System | Neuroendocrine Tumors | 06/24 | 06/24 | | |
| Jonnalagadda, Srinivas |
| Recruiting | N/A | 234 | Europe, Canada, US | ERCP with miES, EUS | Oregon Health and Science University, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Pancreatitis, Pancreas Divisum, Pancreatitis, Acute, Pancreatitis Idiopathic, Pancreas Inflamed | 02/27 | 09/27 | | |
| Ebuh, Valentine |
NCT05590403 / 2022-001981-36: A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 50-59 Years of Age, Including Adults at Increased Risk of Respiratory Syncytial Virus Lower Respiratory Tract Disease, Compared to Older Adults 60 Years of Age and Above |
|
|
| Completed | 3 | 1544 | Europe, Canada, Japan, US, RoW | RSVPreF3 OA investigational vaccine, Placebo | GlaxoSmithKline | Respiratory Syncytial Virus Infections | 03/23 | 04/24 | | |
| Completed | 3 | 4223 | Europe, US | ABNCoV2, Comirnaty | Bavarian Nordic | COVID-19 Disease | 03/23 | 10/23 | | |
NCT05392075: COVID-19 Breakthrough Infection in Fully Vaccinated People and in People Who Received a Booster Dose |
|
|
| Completed | N/A | 100 | US | Pfizer COVID-19 mRNA vaccine, Moderna COVID-19 mRNA vaccine | Methodist Health System | COVID-19 Pneumonia, COVID-19 | 03/23 | 08/23 | | |
| Ahn, Sam S |
NCT04054440: Outpatient Office Based Endovascular Procedures |
|
|
| Enrolling by invitation | N/A | 300 | US | | Methodist Health System | Chronic Venous Insufficiency, Peripheral Arterial Disease, Dialysis Access Malfunction, Arterio-venous Fistula, Thoracic Outlet Syndrome, Vertebral Artery Insufficiency, Varicose Veins | 05/24 | 05/24 | | |
| Rago, Jessica |
NCT04153604: Doxycycline for the Prevention of Spontaneous Bacterial Peritonitis |
|
|
| Completed | N/A | 841 | US | doxycycline | Methodist Health System | Cirrhosis, Spontaneous Bacterial Peritonitis | 08/20 | 08/20 | | |
| Brown, Crystal |
| Recruiting | 2 | 60 | US | Promoting Resilience in Stress Management (PRISM) | University of Washington, National Institute on Minority Health and Health Disparities (NIMHD) | Discrimination, Racial, Communication, Chronic Illness, Bias, Racial | 07/24 | 07/24 | | |
| Enrolling by invitation | N/A | 400 | US | No intervention | Methodist Health System | Heart Failure | 08/24 | 09/24 | | |
| Recruiting | N/A | 800 | US | SPARK Test | Spark Neuro Inc. | Alzheimer Disease, Cognitive Impairment | 05/25 | 11/25 | | |
NCT05168787: Efficacy and Safety of Sacubitril/Valsartan in African American Patients With Heart Failure With Reduced Ejection Fraction |
|
|
| Enrolling by invitation | N/A | 352 | US | sacubitril/valsartan | Methodist Health System | Heart Failure | 08/24 | 08/24 | | |
| Reiter, Tamara |
NCT06096051: Evaluation of 4-Factor PCC in DOAC-associated Intracranial Hemorrhage |
|
|
| Recruiting | N/A | 100 | US | Use of fixed-dosed 4F-PCC | Methodist Health System | Intracranial Hemorrhage | 07/24 | 07/24 | | |
NCT06025162: Evaluation of Chemical Venous Thromboembolism Prophylaxis in Trauma |
|
|
| Enrolling by invitation | N/A | 100 | US | enoxaparin, Accessing for contraindication for chemical VTE prophylaxis | Methodist Health System | Thromboembolism, Venous | 08/24 | 08/24 | | |
NCT05264246: Evaluation of an Anti-Shivering Protocol Cardiac Arrest |
|
|
| Recruiting | N/A | 400 | US | | Methodist Health System | Cardiac Arrest | 09/24 | 09/24 | | |
| Truitt, Michal |
NCT04181801: Subtotal Cholecystectomy for Complicated Acute Cholecystitis: a Multicenter Prospective Observational Study |
|
|
| Recruiting | N/A | 500 | US | Subtotal cholecystectomy | Methodist Health System | Subtotal Cholecystectomy, Complicated Acute Cholecystitis | 11/22 | 11/22 | | |
| Cooper, Crystee |
| Recruiting | N/A | 30 | US | | Methodist Health System | Esophageal Cancer | 06/25 | 06/25 | | |
| Completed | N/A | 4 | US | Emergency general surgery | Methodist Health System | Emergency General Surgery | 11/20 | 11/20 | | |
NCT05226793: Medication Use Evaluation for Enoxaparin in Hospitalized COVID-19 Patients |
|
|
| Recruiting | N/A | 400 | US | | Methodist Health System | Venous Thromboembolism | 11/24 | 11/24 | | |
NCT04181801: Subtotal Cholecystectomy for Complicated Acute Cholecystitis: a Multicenter Prospective Observational Study |
|
|
| Recruiting | N/A | 500 | US | Subtotal cholecystectomy | Methodist Health System | Subtotal Cholecystectomy, Complicated Acute Cholecystitis | 11/22 | 11/22 | | |
NCT05262140: In Vivo Quantification of Cervical Collar Efficacy |
|
|
| Recruiting | N/A | 60 | US | | Methodist Health System | Spine Injury | 01/25 | 01/25 | | |
NCT05087550: Multicenter Study on Organ Acquisition Costs in the Post Re-Allocation Era: Liver Transplantation |
|
|
| Completed | N/A | 186 | US | Liver Transplantation | Methodist Health System, Washington University School of Medicine | Liver Transplant | 06/23 | 08/23 | | |
| Completed | N/A | 500 | US | Trauma Specific Frailty Index Questionnaire, Trauma Specific Frailty Index | Methodist Health System | Physical Trauma | 08/23 | 08/23 | | |
| Recruiting | N/A | 30 | US | | Methodist Health System | Alcoholic Hepatitis, Acute Liver Failure | 12/24 | 12/24 | | |
NCT05935267: Thoracostomy Tube Irrigation: A Multi-Center Trial |
|
|
| Recruiting | N/A | 1000 | US | thoracic irrigation | Methodist Health System | Thoracic Trauma | 12/24 | 12/24 | | |
NCT05224713: Correlations Between Press Ganey Hospital and Ambulatory Scores for a Neurosurgical Practice |
|
|
| Recruiting | N/A | 1800 | US | | Methodist Health System | Satisfaction, Patient | 07/24 | 07/24 | | |
NCT04564599: The Rise of Ride Sharing Companies and Trends in Impaired Driving Accidents |
|
|
| Active, not recruiting | N/A | 100 | US | | Methodist Health System | Ride Sharing, Alcohol Drinking, Alcohol Intoxication, Drug Use, Motor Collision, Sexual Assault | 07/24 | 07/24 | | |
NCT06112938: Alternative Treatment Strategies for Stenotrophomonas Maltophilia Pneumonia |
|
|
| Recruiting | N/A | 400 | US | Antibiotic | Methodist Health System | Stenotrophomonas Maltophilia Infection | 07/24 | 07/24 | | |
NCT04477889: Methodist Health System COVID-19 Patient Registry |
|
|
| Recruiting | N/A | 500 | US | Treatment for COVID-19 | Methodist Health System | COVID-19 | 12/25 | 12/26 | | |
NCT05595031: Evaluation of the Clinical Impact of Corticosteroid Duration on SARS-CoV-2 (COVID-19 WHO) |
|
|
| Recruiting | N/A | 400 | US | | Methodist Health System | Covid 19 | 10/23 | 10/23 | | |
NCT05595057: Coping, Perceived Meaning, Joy, Horizontal Civility at Work |
|
|
| Recruiting | N/A | 105 | US | | Methodist Health System | Workplace Incivility, Joy, Self Efficacy | 12/23 | 12/23 | | |
NCT05264246: Evaluation of an Anti-Shivering Protocol Cardiac Arrest |
|
|
| Recruiting | N/A | 400 | US | | Methodist Health System | Cardiac Arrest | 09/24 | 09/24 | | |
| DiPasquale, Allison |
RCT, NCT05113927: Wide Field OCT + AI for Positive Margin Rates in Breast Conservation Surgery. |
|
|
| Recruiting | N/A | 531 | US | Selene | Perimeter Medical Imaging, Cancer Prevention Research Institute of Texas, Proxima Clinical Research, Biostatistical Consulting, Inc. | Breast Cancer | 10/24 | 01/25 | | |
| Truitt, Michael |
NCT06223620: A Multicenter Retrospective Review of Management Strategies in Small Bowel Obstruction |
|
|
| Completed | N/A | 504 | US | review performance of water soluble contrast | Methodist Health System | SBO - Small Bowel Obstruction | 12/19 | 12/19 | | |
NCT04640701: Obesity in G60 Trauma Patients / Obesity in G60 Trauma Patients |
|
|
| Completed | N/A | 100 | US | | Methodist Health System | Obesity | 05/22 | 05/22 | | |
| Completed | N/A | 4 | US | Emergency general surgery | Methodist Health System | Emergency General Surgery | 11/20 | 11/20 | | |
NCT05224817: NECROtizing Soft Tissue Infections and Their Scoring System |
|
|
| Recruiting | N/A | 1010 | US | Necrotizing soft tissue infections (NSTIs) | Methodist Health System | Necrosis | 12/22 | 01/23 | | |
| Enrolling by invitation | N/A | 150 | US | pre-hospital tourniquet placement | Methodist Health System | Extremity Injury | 01/23 | 01/23 | | |
| Recruiting | N/A | 1000 | US | Antibiotics, Ampicillin, Ancef, Erythro | Methodist Health System | Trauma Injury | 07/24 | 07/24 | | |
NCT05935267: Thoracostomy Tube Irrigation: A Multi-Center Trial |
|
|
| Recruiting | N/A | 1000 | US | thoracic irrigation | Methodist Health System | Thoracic Trauma | 12/24 | 12/24 | | |
NCT04564599: The Rise of Ride Sharing Companies and Trends in Impaired Driving Accidents |
|
|
| Active, not recruiting | N/A | 100 | US | | Methodist Health System | Ride Sharing, Alcohol Drinking, Alcohol Intoxication, Drug Use, Motor Collision, Sexual Assault | 07/24 | 07/24 | | |
NCT05171010: Geri-TBI: A Prospective Multi-center Evaluation of Geriatric Patients With Traumatic Brain Injury |
|
|
| Completed | N/A | 69 | US | no study-based therapeutic interventions | Methodist Health System | Traumatic Brain Injury | 09/20 | 09/20 | | |
| Amos, Joseph D |
NCT06136273: Penetrating Trauma Registry and Open Source Data |
|
|
| Recruiting | N/A | 200 | US | Treatment measures and intervention strategies, Injury prevention | Methodist Health System | Penetrating Trauma Registry and Open Source Data | 08/25 | 08/25 | | |
| Completed | N/A | 500 | US | Trauma Specific Frailty Index Questionnaire, Trauma Specific Frailty Index | Methodist Health System | Physical Trauma | 08/23 | 08/23 | | |
